Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Intensive Chemotherapy (IC) Followed By Oral Azacitidine (AZA) Maintenance Versus Venetoclax (VEN) Plus AZA for Patients (pts) with Acute Myeloid Leukemia (AML): Retrospective Analysis of an Electronic Medical Record (EMR) Database in the United States

Alice Mims, Zhuoer Xie, Alberto Vasconcelos, Maria Strocchia, Lona Gaugler, Sara Vergara, Ying Qiu, David Rotter, Ravi Potluri, Thomas Prebet, Jan Sieluk

Blood (2023) 142 (Supplement 1): 550.

https://doi.org/10.1182/blood-2023-173442

Published: 2023

Journal Articles

Treatment Patterns and Outcomes of Patients with Acute Myeloid Leukemia (AML) from 2013 to 2022: A Connect ® Myeloid Registry Study

David L. Grinblatt, Gail J. Roboz, Daniel A. Pollyea, Mikkael A. Sekeres, Bart L. Scott, Karen Seiter, Amer M. Zeidan, Jay L. Patel, Guillermo Garcia-Manero, Rami S. Komrokji, Michael R. Savona, Irene S. Degutis, Pavel Kiselev, Edward Yu, Willem Heydendael, Ying Qiu, Sara Vergara, Ali McBride, Harry P. Erba

Blood (2023) 142 (Supplement 1): 593.

https://doi.org/10.1182/blood-2023-189963

Published: 2023

Journal Articles

Real-World (RW) Evaluation of Acute Myeloid Leukemia (AML) Induction Therapies in the Community Setting: A Retrospective Evaluation of Outcomes of Intensive Chemotherapy, Venetoclax-Based Regimens, and Non-IC-Based Treatments

Keri Maher, Cherrishe Brown-Bickerstaff, Ali McBride, Ajeet Gajra, Djibril Liassou, Ying Qiu, Marné Garretson, JaLyna Laney, David Huggar, David Hughes

Blood (2022) 140 (Supplement 1): 13278–13279.

https://doi.org/10.1182/blood-2022-169762

Published: 2022

Journal Articles

Clinical Outcomes Among Patients with Myelodysplastic Syndromes Treated with Iron Chelation Therapy: A Real World Medicare Database Study

Yanni Hao, PhD, Alex Z Fu, PhD, Austin Coe, Ying Qiu, PhD, Zhiyi Li, Becky Hanna, Jackson Tang, Brian M. Elliott, MD, Carole Paley, MD

Blood (2016) 128 (22): 2396.

https://doi.org/10.1182/blood.V128.22.2396.2396

Published: 2016

Journal Articles

Treatment Patterns and Adherence Among Patients with Myelodysplastic Syndromes Receiving Deferasirox As Iron Chelation Therapy: A Real World Medicare Database Study

Alex Z Fu, PhD, Yanni Hao, PhD, Austin Coe, Ying Qiu, PhD, Zhiyi Li, Becky Hanna, Jackson Tang, Brian M. Elliott, MD, Carole Paley, MD

Blood (2016) 128 (22): 4759.

https://doi.org/10.1182/blood.V128.22.4759.4759

Published: 2016

Journal Articles

Epidemiologic and Clinical Characteristics of Thalassemia (Thal) Intermedia (TI) in the United States

Elliott P. Vichinsky, MD, Janet Kwiatkowski, MD, Patricia J. Giardina, MD, Carole Paley, MD, Francis Vekeman, MA, Wendy Y. Cheng, MPH, MPhil, Joseph Damron, BA, Nora McCormick, MSc, Medha Sasane, PhDBPharm,MS, Ying Qiu, PhD, Mei Sheng Duh, MPH, ScD, Alexis A. Thompson, MD

Blood (2015) 126 (23): 3279.

https://doi.org/10.1182/blood.V126.23.3279.3279

Published: 2015

Journal Articles

Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of High-Risk Leukemia

Wu Depei, Xiao wen Tang, Ai ning Sun, Zheng -zheng Fu, Miao Miao, zheng Ming Jin, Hui ying Qiu, Wei rong Chang, Xia ming Zhu

Blood (2008) 112 (11): 4418.

https://doi.org/10.1182/blood.V112.11.4418.4418

Published: 2008

Journal Articles

The Clinical Features and the Efficient Therapy of 66 Acute Promyelocytic Leukemia Patients with High Initial White Blood Cell Count.

Hui-ying Qiu, MD, PhD, Meng-xing Xue, PhD, Ai-ning Sun, MD, PhD, Yue-jun Liu, MD, PhD, De Pei Wu, MD, PhD

Blood (2007) 110 (11): 4363.

https://doi.org/10.1182/blood.V110.11.4363.4363

Published: 2007

Journal Articles

FLT3 Mutation in Patients with Acute Promyelocytic Leukemia Has No Effect on Therapy Response.

Meng Xing Xue, PhD, Hui Ying Qiu, MD PhD, Yu Feng Feng, MD PhD, Jin Lan Pan, MD PhD, Su Ning Chen, MD PhD, De Pei Wu, MD PhD

Blood (2007) 110 (11): 4239.

https://doi.org/10.1182/blood.V110.11.4239.4239

Published: 2007

Journal Articles

Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report

Dao-Pei Lu, Jing-Ying Qiu, Bin Jiang, Qin Wang, Kai-Yan Liu, Yan-Rong Liu, Shan-Shan Chen

Blood (2002) 99 (9): 3136–3143.

https://doi.org/10.1182/blood.V99.9.3136

Published: 2002

NARROW

Intensive Chemotherapy (IC) Followed By Oral Azacitidine (AZA) Maintenance Versus Venetoclax (VEN) Plus AZA for Patients (pts) with Acute Myeloid Leukemia (AML): Retrospective Analysis of an Electronic Medical Record (EMR) Database in the United States

Treatment Patterns and Outcomes of Patients with Acute Myeloid Leukemia (AML) from 2013 to 2022: A Connect ® Myeloid Registry Study

Real-World (RW) Evaluation of Acute Myeloid Leukemia (AML) Induction Therapies in the Community Setting: A Retrospective Evaluation of Outcomes of Intensive Chemotherapy, Venetoclax-Based Regimens, and Non-IC-Based Treatments

Clinical Outcomes Among Patients with Myelodysplastic Syndromes Treated with Iron Chelation Therapy: A Real World Medicare Database Study

Treatment Patterns and Adherence Among Patients with Myelodysplastic Syndromes Receiving Deferasirox As Iron Chelation Therapy: A Real World Medicare Database Study

Epidemiologic and Clinical Characteristics of Thalassemia (Thal) Intermedia (TI) in the United States

Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of High-Risk Leukemia

The Clinical Features and the Efficient Therapy of 66 Acute Promyelocytic Leukemia Patients with High Initial White Blood Cell Count.

FLT3 Mutation in Patients with Acute Promyelocytic Leukemia Has No Effect on Therapy Response.

Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only